Arcadia Biosciences (RKDA) Change in Cash (2014 - 2025)

Arcadia Biosciences has reported Change in Cash for 12 years, with the latest figure at -$861000.0 in Q4 2025.

• For the quarter ending Q4 2025, Change in Cash fell 381.37% year-over-year to -$861000.0; the trailing twelve-month figure through Dec 2025 stood at -$4.0 million (down 75.0% YoY), and the FY2025 full-year result was -$4.0 million, down 75.0% from the prior year.
• Change in Cash for Q4 2025 stood at -$861000.0, down from -$256000.0 in the prior quarter.
• The five-year high for Change in Cash was $16.8 million in Q1 2021, with the low at -$9.5 million in Q2 2023.
• Historically, Change in Cash has averaged -$789200.0 across 5 years, with a median of -$1.7 million in 2024.
• Annual changes were most pronounced in 2021 — Change in Cash jumped 268.85% — and 2025, when it plunged 381.37%.
• Arcadia Biosciences' Change in Cash stood at -$6.8 million in 2021, then surged by 69.67% to -$2.1 million in 2022, then slumped by 97.25% to -$4.1 million in 2023, then surged by 107.48% to $306000.0 in 2024, then sank by 381.37% to -$861000.0 in 2025.
• The last three Change in Cash figures came in at -$861000.0 (Q4 2025), -$256000.0 (Q3 2025), and -$1.8 million (Q2 2025), per Business Quant data.